December 2018

Cannabis growing practices and the use of potentially harmful chemical additives

With the growth of legal cannabis markets there has been recognition of the adverse impacts of certain cannabis growing practices, notably, use of harmful chemicals.

Read more
December 2018

Evaluation of a workplace alcohol and other drug program

Risky AOD use in workplaces is pervasive in some workplace cultures and is often associated with risks to the health, safety and productivity of workers and organisations.

December 2018

Insomnia and regulation of sleep-wake cycle with drugs among adolescent risky drinkers

In this study, the authors aimed to explore symptoms of insomnia in a group of youths characterised as engaging in risky drinking.

December 2018

Wellbeing and coping strategies of alcohol and other drug therapeutic community workers: A qualitative study

The purpose of this paper is to examine the strategies utilised to facilitate the wellbeing of workers of an alcohol and other drug (AOD) therapeutic community (TC).

December 2018

Mother–Infant and Partner–Infant Emotional Availability at 12 Months of Age: Findings From an Australian Longitudinal Study

The aim of this study was to examine the influence of mother–infant and partner–infant bonding, mental ill‐health and substance use at 8 weeks post birth on mother–infant and partner–infant EA at 12 months post birth, accounting for a range of demographic and postnatal variables.

December 2018

Understanding an emerging treatment population: Protocol for and baseline characteristics of a prospective cohort of people receiving treatment for pharmaceutical opioid dependence

Despite large increases in pharmaceutical opioid dependence and related mortality, few studies have focused on the characteristics and treatment experiences of those with pharmaceutical opioid dependence.

October 2018

Characteristics and wellbeing of the NSW non-government AOD Workforce

This report highlights the findings of a NSW survey which mapped the demographic profile of NSW non-government AOD workers and gauged their level of health and wellbeing.

October 2018

Typology of new psychoactive substance use among the general Australian population

The aim of this study was to examine the typology of Australian illicit drug consumers to determine whether those who use new psychoactive substances (NPS) differ from those using other illicit substances.

October 2018

Behind closed doors: The priorities of the alcohol industry

The aim of this study was to assess industry strategic approaches as communicated in articles published in a leading Australian alcohol trade magazine to provide insights for policy makers and advocacy groups.

October 2018

Cannabis and cannabinoids for the treatment of people with chronic non-cancer pain conditions

This review examines evidence for the effectiveness of cannabinoids in chronic noncancer pain (CNCP) and addresses gaps in the literature.

October 2018

Using routinely collected data to understand and predict adverse outcomes in opioid agonist treatment

There is a need to better understand risk for adverse outcomes during and after OAT, and for innovative approaches to identifying people at greatest risk of adverse outcomes.

Pages